Barts-MS rose-tinted-odometer: ★★★★★★ (A golden 6-star Thursday, #d4af37)
The great news, our triMS.online conference won the industry Communiqué Award for ‘Excellence in Global Education Meetings/Stand-Alone Events’ last night. What started as an idea on this blog back in October 2016 became a reality in 2018 and is now hopefully a permanent fixture in the MS calendar. This was a real team effort and it is thanks to the dedication and commitment of the teams at Oxford Health Policy Forum and Oxford Pharmagenesis that this was possible. The common denominator to everything that I have been involved in that has been successful is good project management and the team at Oxford Pharmagenesis are by the far the most talented and professional team I have worked with. Thank you and well done. This is also the team behind the success of the ‘Brain Health: Time Matters‘ policy initiative.
A big thank you to the triMS.online steering committee who help with designing and implementing the different programmes. The founding principles of triMS.online were to increase global access to MS meetings, particularly for HCPs living in low and middle-income countries and at the same time to increase the diversity of speakers, particularly women, young people and people from ethnic minorities. This was acknowledged by the judges and I suspect was the main reason behind us winning the award.
I also want to thank our Pharmaceutical partners who have sponsored these meetings. Without your support triMS.online would not have become a reality.
Where to next? Because of the pharmaceutical code of conduct that does not allow pwMS to attend triMS.online we are creating a separate meeting for pwMS called PRISMS (patient reflections and insights in MS). Our first meeting is called ‘Shining a light on MS learnings from the COVID-19 pandemic’ and will be on Thursday 23 September 2021m 19:30 – 20:30 BST (14:30 – 15:30 EDT / 20:30 – 21:30 CEST). If you have not registered yet please do.
General Disclaimer: Please note that the opinions expressed here are those of Professor Giovannoni and do not necessarily reflect the positions of the Barts and The London School of Medicine and Dentistry nor Barts Health NHS Trust and are not meant to be interpreted as personal clinical advice.